The inhibition of the JAK/STAT pathway has been used to prevent gene expression regulated by disease-associated proinflammatory cytokines, and several JAK-blocking drugs have been approved, which are used for the treatment of rheumatoid arthritis (RA) or psoriatic arthritis (37). This evidence concerns the gene SOAT1 and rheumatoid arthritis.